NAUT

NAUT

USD

Nautilus Biotechnolgy Inc. Common Stock

$0.677-0.009 (-1.383%)

即時價格

Healthcare
生物科技
美國

價格圖表

Loading Chart...

關鍵指標

市場指標
公司基本面
交易統計

市場指標

開盤

$0.687

最高

$0.708

最低

$0.673

交易量

0.02M

公司基本面

市值

85.5M

行業

生物科技

國家

United States

交易統計

平均交易量

0.16M

交易所

NMS

貨幣

USD

52週範圍

最低 $0.66當前 $0.677最高 $3.09

AI分析報告

最後更新: 2025年5月4日
由AI生成數據來源: Yahoo Finance, Bloomberg, SEC

NAUT (Nautilus Biotechnology Inc. Common Stock): What's Happening and What to Watch

Stock Symbol: NAUT Generate Date: 2025-05-04 17:20:18

Alright, let's break down what's going on with Nautilus Biotechnology based on the latest info we've got. Think of this as a quick chat about the stock's recent moves and what might be coming up.

Recent News Buzz

The main piece of news we have is pretty straightforward: Nautilus announced they'll be sharing their first-quarter 2025 financial results on April 29th. This kind of announcement is standard stuff for a company. It tells investors when they'll get the latest look at the company's performance – how much money they made (or didn't), expenses, and so on.

Now, while this specific news item is just a date announcement, the overall "vibe" or sentiment around the stock, according to some analysis tools, seems to be leaning positive right now. It's possible the market is anticipating good results, or maybe there's other positive chatter out there not captured in this single headline. The upcoming earnings call is definitely the big event on the horizon that everyone will be waiting for.

Checking the Price Action

Looking back over the last few months, the picture for NAUT's stock price hasn't been pretty. It's been on a noticeable slide, dropping from the $1.70 range back in February down into the $0.60s more recently. There was a particularly sharp dip around late February.

Lately, though, things have calmed down a bit. The price has been bouncing around in a tighter range, mostly between roughly $0.67 and $0.83 through April and into May. The last price point we have is around $0.68.

Comparing this to the AI's short-term look ahead, the prediction is for the price to stay flat today, then potentially tick up a bit over the next couple of days (around +3% and +4%). This suggests the AI sees the recent downward pressure easing up, at least for the immediate future.

Putting It All Together: What Might Be Next?

So, we've got a stock that's been trending down but seems to have found a floor recently. We have an important date coming up with the earnings report, and despite the recent price history, there's a reported positive sentiment floating around, plus AI predictions pointing to a potential near-term bounce.

Based on these pieces – the AI's forecast for upward movement, the reported positive sentiment (perhaps anticipating earnings), and the stock trading near its recent lows – the situation might suggest a potential opportunity for those looking to buy, if they believe these positive indicators outweigh the recent downward trend.

  • Potential Entry Idea: If you were considering getting in, the current price area, around $0.68-$0.70, looks interesting. Why? Because it's right where the stock has been finding some support lately, and it aligns with entry points suggested by some analysis tools. It's essentially near the bottom of its recent trading range.
  • Managing Risk: Nobody knows for sure which way a stock will go. If you decide to jump in, thinking about where you'd get out is crucial. A potential level to consider taking some profit, based on the AI's very short-term prediction, could be around $0.71. For a stop-loss – the point where you'd sell to limit potential losses if the price keeps falling – a level like $0.61 has been suggested by some analysis. This is below the recent 52-week low, so it gives the stock some room, but it's important to pick a level you're comfortable with. Remember, these are just ideas based on the data points we have.

A Little Company Context

Just a quick reminder about Nautilus Biotechnology itself: they're a biotech company working on technology to analyze proteins. This means their progress and financial health are tied to developing and selling this specialized platform. News about their technology, research milestones, or, critically, their financial performance (like the upcoming earnings report) can have a big impact on the stock price. They are also a relatively small company by market value, which can sometimes mean bigger price swings.


Disclaimer: This analysis is based solely on the provided data and is for informational purposes only. It is not financial advice. Stock investing involves risk, and you could lose money. Always do your own thorough research or consult with a qualified financial advisor before making any investment decisions.

相關新聞

GlobeNewswire

Nautilus Biotechnology to Announce First Quarter 2025 Financial Results on April 29, 2025

SEATTLE, April 16, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ:NAUT, or "Nautilus")), a company pioneering a single-molecule proteome analysis platform, today announced it will report financial

查看更多
Nautilus Biotechnology to Announce First Quarter 2025 Financial Results on April 29, 2025

AI預測Beta

AI推薦

看漲

更新於: 2025年5月4日 下午02:57

看跌中立看漲

66.2% 信心度

風險與交易

風險級別4/5
高風險
適合
價值
交易指南

入場點

$0.69

獲利了結

$0.71

止損

$0.61

關鍵因素

當前價格比 MA(20) 的 $0.69 低 2.2%,顯示下行動能
RSI 為 30.0,表明超賣情況,預示潛在的強勁反轉
DMI 顯示熊市趨勢 (ADX:17.6, +DI:10.7, -DI:24.7),建議謹慎
當前價格非常接近支撐位 ($0.68),表明強勁的買入機會
交易量是平均值 (3,086) 的 2.7 倍,顯示出顯著的買入興趣
MACD -0.0032 在信號線 -0.0016 下方,表示看跌交叉

保持更新

設定價格提醒,獲取AI分析更新和即時市場新聞。